Class II phosphoinositide 3-kinase defines a novel signaling pathway in cell migration

被引:129
作者
Maffucci, T
Cooke, FT
Foster, FM
Traer, CJ
Fry, MJ
Falasca, M
机构
[1] UCL, Sackler Inst, Dept Med, London WC1E 6JJ, England
[2] UCL, Dept Biochem & Mol Biol, London WC1E 6BT, England
[3] Univ Reading, Sch Anim & Microbial Sci, Reading RG6 6AJ, Berks, England
基金
英国惠康基金;
关键词
D O I
10.1083/jcb.200408005
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The lipid products of phosphoinositide 3-kinase (PI3K) are involved in many cellular responses such as proliferation, migration, and survival. Disregulation of PI3K-activated pathways is implicated in different diseases including cancer and diabetes. Among the three classes of PI3Ks, class I is the best characterized, whereas class II has received increasing attention only recently and the precise role of these isoforms is unclear. Similarly, the role of phosphatidylinositol-3-phosphate (PtdIns-3-P) as an intracellular second messenger is only just beginning to be appreciated. Here, we show that lysophosphatidic acid (LPA) stimulates the production of PtdIns-3-P through activation of a class II PI3K (PI3K-C2 beta). Both PtdIns-3-P and PI3K-C2 beta are involved in LPA-mediated cell migration. This study is the first identification of PtdIns-3-P and PI3K-C2 beta as downstream effectors in LPA signaling and demonstration of an intracellular role for a class II PI3K. Defining this novel PI3K-C2 beta- PtdIns-3-P signaling pathway may help clarify the process of cell migration and may shed new light on PI3K-mediated intracellular events.
引用
收藏
页码:789 / 799
页数:11
相关论文
共 42 条
[1]   ZD1839 (Iressa), a novel epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, potently inhibits the growth of EGFR-positive cancer cell lines with or without erbB2 overexpression [J].
Anderson, NG ;
Ahmad, T ;
Chan, K ;
Dobson, R ;
Bundred, NJ .
INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (06) :774-782
[2]   Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation [J].
Arcaro, A ;
Khanzada, UK ;
Vanhaesebroeck, B ;
Tetley, TD ;
Waterfield, MD ;
Seckl, MJ .
EMBO JOURNAL, 2002, 21 (19) :5097-5108
[3]   Class II phosphoinositide 3-kinases are downstream targets of activated polypeptide growth factor receptors [J].
Arcaro, A ;
Zvelebil, MJ ;
Wallasch, C ;
Ullrich, A ;
Waterfield, MD ;
Domin, J .
MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (11) :3817-3830
[4]   Human phosphoinositide 3-kinase C2β, the role of calcium and the C2 domain in enzyme activity [J].
Arcaro, A ;
Volinia, S ;
Zvelebil, MJ ;
Stein, R ;
Watton, SJ ;
Layton, MJ ;
Gout, I ;
Ahmadi, K ;
Downward, J ;
Waterfield, MD .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (49) :33082-33090
[5]   Lysophosphatidic acid stimulates ovarian cancer cell migration via a Ras-MEK kinase 1 pathway [J].
Bian, DF ;
Su, SB ;
Mahanivong, C ;
Cheng, RK ;
Han, QW ;
Pan, ZXK ;
Sun, PQ ;
Huang, S .
CANCER RESEARCH, 2004, 64 (12) :4209-4217
[6]   Insulin activates the α isoform of class II phosphoinositide 3-kinase [J].
Brown, RA ;
Domino, J ;
Arcaro, A ;
Waterfield, MD ;
Shepherd, PR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (21) :14529-14532
[7]   Growth factor regulation of the novel class II phosphoinositide 3-kinases [J].
Brown, RA ;
Shepherd, PR .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2001, 29 :535-537
[8]   The phosphoinositide 3-kinase pathway [J].
Cantley, LC .
SCIENCE, 2002, 296 (5573) :1655-1657
[9]  
Chau TT, 2003, MARINE MARITIME, V3, P3
[10]   Analysis of gene function in somatic mammalian cells using small interfering RNAs [J].
Elbashir, SM ;
Harborth, J ;
Weber, K ;
Tuschl, T .
METHODS, 2002, 26 (02) :199-213